INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 155 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2017. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $8,749,000 | +87.7% | 70,605 | +0.5% | 0.06% | +71.9% |
| Q3 2019 | $4,660,000 | +2673.8% | 70,222 | +3245.5% | 0.03% | +3100.0% |
| Q2 2019 | $168,000 | -49.2% | 2,099 | -29.0% | 0.00% | -66.7% |
| Q1 2019 | $331,000 | +40.3% | 2,958 | +25.6% | 0.00% | +50.0% |
| Q4 2018 | $236,000 | -75.4% | 2,355 | -69.0% | 0.00% | -75.0% |
| Q3 2018 | $961,000 | -4.9% | 7,599 | -53.7% | 0.01% | -11.1% |
| Q2 2018 | $1,010,000 | 0.0% | 16,422 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $1,010,000 | +169.3% | 16,422 | +156.0% | 0.01% | +125.0% |
| Q4 2017 | $375,000 | -14.8% | 6,415 | -15.4% | 0.00% | -20.0% |
| Q3 2017 | $440,000 | +88.0% | 7,582 | +292.0% | 0.01% | +66.7% |
| Q2 2017 | $234,000 | +35.3% | 1,934 | +26.1% | 0.00% | +50.0% |
| Q1 2017 | $173,000 | -2.8% | 1,534 | -5.9% | 0.00% | 0.0% |
| Q4 2016 | $178,000 | -7.8% | 1,630 | +39.6% | 0.00% | -33.3% |
| Q3 2016 | $193,000 | +17.0% | 1,168 | +1.0% | 0.00% | 0.0% |
| Q2 2016 | $165,000 | +60.2% | 1,156 | +43.8% | 0.00% | +50.0% |
| Q1 2016 | $103,000 | -14.2% | 804 | +0.1% | 0.00% | 0.0% |
| Q4 2015 | $120,000 | -7.7% | 803 | +2.4% | 0.00% | -33.3% |
| Q3 2015 | $130,000 | -21.2% | 784 | +15.0% | 0.00% | 0.0% |
| Q2 2015 | $165,000 | -21.1% | 682 | -8.1% | 0.00% | -25.0% |
| Q1 2015 | $209,000 | +97.2% | 742 | +8.8% | 0.00% | +100.0% |
| Q4 2014 | $106,000 | -44.5% | 682 | -15.5% | 0.00% | -60.0% |
| Q3 2014 | $191,000 | +51.6% | 807 | +52.0% | 0.01% | +66.7% |
| Q2 2014 | $126,000 | +281.8% | 531 | +431.0% | 0.00% | +200.0% |
| Q1 2014 | $33,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $53,308,000 | 10.69% |
| Senvest Management, LLC | 976,127 | $81,907,000 | 5.65% |
| Melqart Asset Management (UK) Ltd | 390,600 | $32,775,000 | 2.80% |
| Asymmetry Capital Management, L.P. | 25,918 | $2,175,000 | 2.14% |
| Elk Creek Partners, LLC | 386,397 | $32,423,000 | 1.78% |
| BB BIOTECH AG | 545,719 | $45,791,000 | 1.32% |
| ALTRINSIC GLOBAL ADVISORS LLC | 383,166 | $32,151,000 | 1.27% |
| DLD Asset Management, LP | 129,000 | $10,824,000 | 0.82% |
| Opus Point Partners Management, LLC | 3,998 | $335,000 | 0.73% |
| Virtus ETF Advisers LLC | 8,970 | $753,000 | 0.67% |